Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT trial: Perfusion balloon plus intracoronary nitroprusside in STEMI PCI
jRCTs051250131Recruiting
- Sponsor
- Kaneka
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium nitroprusside in myocardial infarction (MI) (2 arms), sponsored by Kaneka. Primary endpoints: TIMI 3 flow achievement at final PCI angiography and Incidence of irregular protrusion on OCT after PCI. Started Dec 2025; status: recruiting.
02
Drugs
sodium nitroprusside
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on jRCTs051250131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250131.